SCHEMBL8201411

SCHEMBL8201411

COc1ccc(CCNC(=O)Cc2ccc(Br)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.68
CA12 O43570 1/20 0.68
CA1 P00915 1/20 0.68
CA2 P00918 1/20 0.68
CA9 Q16790 1/20 0.68
FPR2 P25090 1/20 0.67
KDM4E B2RXH2 1/20 0.65
GLA P06280 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
MEN1 O00255 1/20 0.63
KMT2A Q03164 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.61
HPGD P15428 1/20 0.61
EGFR P00533 1/20 0.60
ERBB2 P04626 1/20 0.60
MAPT P10636 1/20 0.60
POLB P06746 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147824 0.89 KDM4E (0.62) ALDH1A1CA12CA1CA2CA9
SCHEMBL8691052 0.87 MAPT (0.76) ALDH1A1CA12CA1CA2CA9
SCHEMBL10568721 0.86 ALDH1A1 (0.72) ALDH1A1CA12CA1CA2CA9
SCHEMBL13723908 0.86 ALDH1A1 (0.72) ALDH1A1CA12CA1CA2CA9
SCHEMBL21328365 0.85 CA1 (0.68) ALDH1A1CA1CA2KDM4EGLA
SCHEMBL15679865 0.84 MEN1 (0.72) KDM4EGLAL3MBTL1MEN1KMT2A
SCHEMBL12773610 0.83 SMN1; SMN2 (0.75) ALDH1A1CA12CA1CA2CA9
SCHEMBL3546981 0.82 MAPT (0.72) ALDH1A1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL10570968 0.82 ALDH1A1 (0.67) ALDH1A1CA12CA1CA2CA9
SCHEMBL3654748 0.82 SMN1; SMN2 (0.69) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043253-A TREATMENT OF DIABETES, OBESITY, LOWERING TRIGLYCERIDE OR CHOLESTEROL LEVELS, INCREASING HIGH DENSITY LIPOPROTEIN LEVELS OR DECREASING GUT MOTILITY, REDUCING NEUROGENIC INFLAMMATION, DEPRESSION OR GASTROINTESTINAL DISORDERS MERCK & CO., INC. (US) 2000-03-28 US disclosed